Stock Events

Hercules Capital 

$21.22
2445
+$0.04+0.19% Friday 20:00

Statistik

Tag Hoch
21.38
Tag Tief
21.17
52W Hoch
21.38
52W Niedrig
14.09
Volumen
1,005,708
Durch. Volumen
743,284
Marktkap.
3.44B
KGV
9.65
Dividendenrendite
7.54%
Dividende
1.6

Demnächst

Dividenden

7.54%Dividendenrendite
10J Wachstumsrate
2.58%
5J Wachstumsrate
4.73%
3J Wachstumsrate
7.44%
1J Wachstumsrate
1.27%

Gewinne

2MayBestätigt
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.36
0.43
0.49
0.56
Erwartetes EPS
0.5
Tatsächliches EPS
0.5

Leute folgen auch

Diese Liste basiert auf den Watchlists von Personen auf Stock Events, die HTGC folgen. Es handelt sich nicht um eine Anlageempfehlung.

Wettbewerber

Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Es ist keine Anlageempfehlung.
Ares Capital
ARCC
Marktkap.12.81B
Die Ares Capital Corporation ist ein führender Wettbewerber im Bereich der Business Development Companies (BDC) und bietet ähnliche Finanzdienstleistungen und Investitionen in mittelständische Unternehmen an.
Golub Capital BDC
GBDC
Marktkap.2.69B
Golub Capital BDC, Inc. bietet Finanzierungslösungen für mittelständische Unternehmen an und konkurriert direkt mit Hercules Capital im selben Sektor.
Prospect Capital
PSEC
Marktkap.2.31B
Prospect Capital Corporation agiert als BDC und investiert in private und mikrokapitalisierte öffentliche Unternehmen, was es zu einem direkten Konkurrenten von Hercules Capital macht.
Main Street Capital
MAIN
Marktkap.4.33B
Main Street Capital Corporation ist eine führende Investmentgesellschaft, die ähnliche Anlagestrategien wie Hercules Capital verfolgt und sich auf Unternehmen im unteren Mittelmarkt konzentriert.
TriplePoint Venture Growth BDC
TPVG
Marktkap.303.9M
TriplePoint Venture Growth BDC Corp. ist auf Investitionen in Wachstumsphasen von Unternehmen spezialisiert und konkurriert eng mit dem Fokus von Hercules Capital auf innovative und technologiegetriebene Unternehmen.
FS KKR Capital
FSK
Marktkap.5.53B
FS KKR Capital Corp. ist ein BDC, der mit Hercules Capital konkurriert, indem er maßgeschneiderte Kreditlösungen für private mittelständische US-Unternehmen anbietet.
Oaktree Specialty Lending
OCSL
Marktkap.1.53B
Oaktree Specialty Lending Corporation ist ein Wettbewerber auf dem BDC-Markt und konzentriert sich auf die Bereitstellung flexibler Finanzierungslösungen für mittelständische Unternehmen.
BlackRock TCP Capital
TCPC
Marktkap.924.38M
BlackRock TCP Capital Corp. ist ein direkter Konkurrent, der Schulden- und Eigenkapitalfinanzierung für mittelständische Unternehmen anbietet, ähnlich dem Investitionsansatz von Hercules Capital.
New Mountain Finance
NMFC
Marktkap.1.32B
New Mountain Finance Corporation konkurriert im Bereich der BDC, indem sie sich auf Schuldtitel und Kredite für mittelständische Unternehmen konzentriert, ähnlich der Strategie von Hercules Capital.
Sixth Street Specialty Lending
TSLX
Marktkap.1.98B
TPG Specialty Lending, Inc. bietet direkte Kredite und Finanzierungslösungen für mittelständische Unternehmen an und konkurriert in der gleichen Nische wie Hercules Capital.

Analystenbewertungen

19.6$Durchschnittliches Kursziel
Die höchste Schätzung ist $21.5.
Von 5 Bewertungen innerhalb der letzten 6 Monate. Dies ist keine Anlageempfehlung.
Kaufen
40%
Halten
60%
Verkaufen
0%

Über

Finance
Investment Managers
Finance and Insurance
Securities and Commodity Exchanges
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million to $250 million in equity per transactions. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; San Diego, California; Westport, Connecticut; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia and London, United Kingdom.
Show more...
CEO
Scott Bluestein
Mitarbeiter
100
Land
US
ISIN
US4270965084
WKN
000A0ERTZ

Börsen